Intrauterine Growth Restriction (IUGR) as a Potential Target for Transamniotic Stem Cell Therapy

Experimental study evaluating transamniotic mesenchymal stem cell therapy (TRASCET) as a potential treatment for intrauterine growth restriction in a hypoxia-induced animal model. Researchers compared outcomes between untreated IUGR fetuses and those receiving intra-amniotic injections of native or cytokine-primed amniotic fluid-derived stem cells.